Rhode Island HB 5494: AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- DRUG COST TRANSPARENCY (Provides drug cost transparency by requiring reports be submitted by drug manufacturers, pharmacy benefit managers and health benefit plan insurers to the director of the department of business regulation regarding drug prices and increases the prices.)

Status: 03/08/2021 Committee recommended measure be held for further study (as of 2021-03-08)

State: Rhode Island · Session: 2021 · Bill: HB 5494

Subjects: Business & Professions, Food and Drugs, Health Care Plans/Services, Prescription drugs

Sponsors: Ackerman, Ajello, Alzate, Filippi, Henries, McNamara, Morales, Potter

View Rhode Island HB 5494 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.